December 2010 - Page 8 of 29

WednesdayDec 22, 2010 8:49 am

CDC Software (CDCS) Integrates Tracking Technology with OnAsset through Strategic Partnership

CDC Software Corp., a hybrid enterprise software provider of on-premise and cloud deployments, yesterday announced its partnership with OnAsset Intelligence Inc., a leading provider of machine-to-machine (M2M) wireless asset tracking, sensing and control solutions. Per the agreement, OnAsset will utilize CDC’s technology to provide enhanced wireless monitoring and sensor data for greater security and business intelligence during the transport of high-value freight. “Real-time asset management is a natural extension of running a smooth supply chain,” Bruce Cameron, president of CDC Software, stated in the press release. “We believe the combination of CDC’s technology with OnAsset’s products offer companies worldwide a…

TuesdayDec 21, 2010 3:14 pm

China Armco Metals, Inc. (CNAM) Updates Investors Regarding Metal Recycling Business

China Armco Metals, Inc., a distributor of metal ore and non-ferrous metals throughout the PRC, today told the investment community it anticipates producing and selling approximately 25,500 tons of recycled steel with an aggregate value of approximately $12 million in the fourth quarter of 2010. The company received orders for the recycled steel from five different customers. With the central government recently announcing that the power rationing for energy intensive industries and steel producers will be phased out, China Armco is optimistic about being able to operate on a full time basis in the near term. "We are encouraged by…

TuesdayDec 21, 2010 3:07 pm

Alanco Technologies, Inc. (ALAN) Subsidiary Receives $2.6 Million Follow-On GenTrak® Order from Major Refrigerated Container Shipping Company

Today before the opening bell, Alanco Technologies, Inc. announced that its subsidiary StarTrak Systems has been awarded a follow-on contract from a current major refrigerated container customer valued at $2.6 million for additional GenTrak® genset-based GPS monitoring systems and a five-year data services agreement. StarTrak has already begun shipping the ordered equipment and anticipates fulfilling the contract by February/March, 2011. The GenTrak® system allows the customer to track remaining fuel, operational status and location of genset-powered refrigerated containers. The system's data services enables StarTrak’s container customer to provide genset / reefer monitoring and management services to third-party shipping companies, allowing…

TuesdayDec 21, 2010 1:24 pm

Ivanhoe Energy Inc. (IVAN) Reports Major Natural Gas Discovery in China, 13 Million Cubic Feet per Day Initial Flow Rate

Ivanhoe Energy, www.ivanhoeenergy.com – has made a name for itself on the global stage as an independent heavy-oil development/production innovator, proudly announcing a major natural gas discovery in China today, with initial flow rates of 13M cubic feet per day. Jointly making the announcement were President and COO of Ivanhoe, David Dyck, Co-Chairman of Sunwing Energy Ltd. (Ivanhoe’s China-focused subsidiary), Robert Friedland and President of Sunwing, Gerry Moench. Dyck praised initial flow rates at the Yixin-2 well, which is situated within Sunwing’s approximately 660k-acre Zitong Block, in one of China’s oldest and most prolific gas regions, the Sichuan Province. The…

TuesdayDec 21, 2010 11:45 am

China Nepstar Chain Drugstore Ltd. (NPD) Video Chart for Tuesday, December 21, 2010

NPD established a very strong resistance level earlier this year around $3.20 before breaking through it to make new highs. The stock price has settled back down on this area again and is on radar to hold the support and trend upward. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

TuesdayDec 21, 2010 11:28 am

Emisphere Technologies (EMIS.OB) Extends Exclusive Agreement with Novo Nordisk (NVO) for Diabetes Treatment

Emisphere Technologies Inc. and Novo Nordisk A/S today announced their extended partnership to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® technology. The exclusive development and license agreement is in line with Novo Nordisk’s overall dedication to diabetes research. "This is an encouraging agreement on a promising technology for oral administration of proteins. We are delighted to continue working with Emisphere and their Eligen® Technology. It fits very well with Novo Nordisk's strategy within diabetes research," Peter Kurtzhals, senior vice president of Diabetes Research Unit at Novo Nordisk stated…

TuesdayDec 21, 2010 10:41 am

Genmed Holding Corp. (GENM.OB) to Enter the European Generic Pharma Market

Genmed Holding Corp. is focused on the delivery of low cost generic pharmaceutical drugs directly to distribution channels throughout the world. The company began its generic business in 2008 and currently operates through its 100%-owned Dutch subsidiary, Genmed B.V. The company announced today its entry into the European generic drug market with the receipt of its first marketing and distribution license for paracetamol. Also known as acetaminophen, paracetamol is an over-the-counter drug used to treat mild to moderate pain from headaches, backaches, osteoarthritis and to reduce fever. Genmed first filed its application paperwork for paracetamol 500 milligram tablets with the…

TuesdayDec 21, 2010 10:27 am

Discover Your Next Profitable Investment with Trader Power

TraderPower was established to empower investors with all the resources they need to make profitable trading decisions. Using the vast resources on the TraderPower website, the investment community can discover undervalued small-cap companies, learn how to properly analyze investment opportunities, and utilize free research tools for in-depth evaluation. TraderPower’s #1 focus is on connecting investors with undervalued small-cap companies that are trading far below their true worth. With an estimated 15,000 publicly traded companies, it’s no surprise that these stocks exist. Of course once these neglected equities begin to get noticed, the climb to their fair valuation can be exceptionally…

TuesdayDec 21, 2010 9:46 am

Sunesis Pharmaceuticals, Inc. (SNSS) Launches Phase 3 VALOR Trial for Vosaroxin Drug

Today, Sunesis Pharmaceuticals, Inc. released updates on its pivotal Phase 3 VALOR trial of vosaroxin, the company’s lead drug candidate in the study of acute myeloid leukemia (AML). Sunesis announced that the first patient has been randomized and dosed with blinded study treatment. The VALOR trial is a multinational, randomized, double-blind, placebo-controlled, pivotal trial which is expected to enroll 450 evaluable patients at leading sites in the U.S., Canada, Europe, Australia and New Zealand. Patients in the VALOR trial will be randomized in blinded manner to receive either vosaroxin or placebo on days one and four of each treatment cycle.…

TuesdayDec 21, 2010 9:43 am

Ivanhoe Energy Inc. (IVAN) Reports Successful Natural Gas Well in China

Ivanhoe Energy Inc. reported the successful completion of a natural gas well at the company’s properties in China. Ivanhoe Energy Inc. said that the Yixin-2 well produced natural gas at a peak rate of 13 million cubic feet per day, with average production between 9 and 10 million cubic feet per day during a 24 hour test period. The well targeted the Xu-4 formation and has been shut in to allow pressure build up. Ivanhoe Energy Inc. reported that the Yixin-2 well was drilled and completed on the Zitgong block located in Sichuan, China. The Zitgong block is approximately 660,000…

Site Search

Company Search

Month: December 2010